Race Oncology Ltd (RAC) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Race Oncology Ltd (RAC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting AU$4.00 (capex AU$4.00 ) from operating cash flow of AU$570.64K. Explore how much does Race Oncology Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
AU$4.00
Capex + Investments
Operating Cash Flow
AU$570.64K
AUD
Capital Expenditures
AU$4.00
AUD
Race Oncology Ltd Cash Flow Reinvestment Rate (2011–2013)
Historical reinvestment intensity for Race Oncology Ltd across 3 annual periods. Also explore RAC asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Race Oncology Ltd (2011–2013)
Year-by-year capital reinvestment analysis for Race Oncology Ltd. For live market cap and broader valuation context, see Race Oncology Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 1.20x | AU$4.44 Million | AU$3.71 Million | AU$31.00K | ▼ -77.5% |
| 2012 | 5.33x | AU$35.61 Million | AU$6.68 Million | AU$218.00K | ▲ +414.5% |
| 2011 | 1.04x | AU$12.34 Million | AU$11.92 Million | AU$72.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow